Ir al contenido

Oncología

Estrategia multimodal, interdisciplinaria e individualizada

Pancreaticoduodenectomy without homologous blood transfusion in an anemic Jehovah's Witness. (abre una nueva ventana)

Atabek U, Spence RK, Pello M, Alexander J, Camishion R.

Fuente‎: Arch Surg 1992;127(3):349-51.

Indexado en‎: PubMed 1347993

https://www.ncbi.nlm.nih.gov/pubmed/1347993 (abre una nueva ventana)

Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's Witness: a strategy to avoid transfusion. (abre una nueva ventana)

Barakat O, Cooper JR Jr, Riggs SA, Hoef JW, Ozaki CF, Wood RP.

Fuente‎: J Surg Oncol 2007;96(3):249-53.

Indexado en‎: PubMed 17443725

DOI‎: 10.1002/jso.20799

https://www.ncbi.nlm.nih.gov/pubmed/17443725 (abre una nueva ventana)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (abre una nueva ventana)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Fuente‎: Transfusion 2016;56(10):2438-42.

Indexado en‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (abre una nueva ventana)

Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. (abre una nueva ventana)

Gross I, Trentino KM, Andreescu A, Pierson R, Maietta RA, Farmer S.

Fuente‎: Oncologist 2016;21(3):327-32.

Indexado en‎: PubMed 26865590

DOI‎: 10.1634/theoncologist.2015-0406

https://www.ncbi.nlm.nih.gov/pubmed/26865590 (abre una nueva ventana)

Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (abre una nueva ventana)

Konstantinidis IT, Allen PJ, D'Angelica MI, Dematteo RP, Fischer ME, Grant F, Fong Y, Kingham TP, Jarnagin WR.

Fuente‎: J Am Coll Surg 2013;217(6):1101-7.

Indexado en‎: PubMed 23880361

DOI‎: 10.1016/j.jamcollsurg.2013.05.020

https://www.ncbi.nlm.nih.gov/pubmed/23880361 (abre una nueva ventana)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (abre una nueva ventana)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Fuente‎: Leuk Res Rep. 2022 25;18:100355.

Indexado en‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (abre una nueva ventana)